Mesothelioma
Science News
San Pedro,
CA - October 15, 2008
Chemotherapy
Assessment of survival and clinical benefit in malignant
pleural mesothelioma patients treated with gemcitabine
and carboplatin Click
here
Diagnosis/staging
CK5/6 in effusions: no difference between mesothelioma and
pulmonary and nonpulmonary adenocarcinoma Click
here
Increased 8-isoprostane, a marker of oxidative stress in
exhaled breath condensate in subjects with asbestos exposure Click
here
Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma Click
here
Peritoneal
mesothelioma
Peritoneal Mesothelioma Click
here
Risk
factors
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related
malignant mesothelioma Click
here
Health Effects of Nanoparticles and Nanomaterials (III) Click
here
Tumor
suppression
Functional
inactivation of NF2/merlin in human mesothelioma
Discussions
Review
and discussion of tumor stage as a prognostic factor for
the outcome of surgery for mesothelioma and its implications
for whether or not a patient is a candidate for surgery Click
here
Review
and discussion of "Open lung-sparing surgery for malignant
pleural mesothelioma: the benefits of a radical approach
within multimodal therapy" by Apostolos Nakas et al.,
European Journal of Cardio-thoracic Surgery, 2008 Click
here